Kathleen L Poston

[Kathleen L Poston @pddoc]

@carlaabdelnour @Stanford_Neuro Awesome!

[Stanford Neurology & Neurological Sciences @Stanford_Neuro]

Registration open for the @Stanford_Neuro 12th Annual Breakthroughs in Neurological Care. Join us for this virtual conference on November 9-10th to learn from @StanfordMed experts on behavioral #neurology, neurocritical care & more! #CME #MedEd

Register: https://t.co/H7fdWDuUDQ

[Stanford Neurology & Neurological Sciences @Stanford_Neuro]

Parkinson's Foundation certifies Stanford Movement Disorders Center as a Center of Excellence, joining a network that is setting the highest standard of care for people with Parkinson’s in the U.S. and internationally. #Parkinsons https://t.co/PhNvyrkr6v

[Kathleen L Poston @pddoc]

At the NYC premiere of #Still at the Lincoln center. Thank you to the #MJFF for arranging for the #PPMI investigators to attend!

[Kathleen L Poston @pddoc]

Always honest and insightful. And a call to action to better treat and find a cure for #parkinsons https://t.co/ncU6hw4rZw

[CNN @CNN]

A lab test that can tell doctors if someone has Parkinson's disease is a long-sought goal of researchers.

There are new tests that are able to detect traces of a key protein that misfolds and gums up specific areas of the brain. https://t.co/pp93V7Hnj5

[The Lancet @TheLancet]

NEW—Identifying ‘hallmark’ Parkinson’s disease protein build-up could aid early detection and pave way for improved diagnosis and treatment , a new study published in @TheLancetNeuro suggests

https://t.co/AgXx2ZCsb2

[Kathleen L Poston @pddoc]

@StanfordNsurg @StanfordBrain Very proud of our amazing surgical #Parkinsons team! They work together to improve the lives of our patients every day.

[Stanford Neurosurgery @StanfordNsurg]

Deep brain stimulation (DBS) procedures use leading-edge techniques, increasing your comfort during surgery.

Our team has performed nearly 1500 DBS procedures since 1999. They are researching new or improved treatments for Parkinson's disease. #ParkinsonsAwarenessMonth

[Stanford Neurology & Neurological Sciences @Stanford_Neuro]

“This opens a new chapter in the diagnosis of Parkinson’s disease, where we can accurately determine alpha-synuclein pathology in living people, and this catalyzes the field forward toward disease-targeted therapeutic development.” - Kathleen L. Poston, MD, MS @pddoc

[Stanford Neurology & Neurological Sciences @Stanford_Neuro]

What lies ahead for the future of Neuroscience and why is Stanford Medicine built to lead transformation in relevant fields of study? Hear from Frank Longo, MD, PhD, Chair of Neurology and Michael Lim, MD, Chair of Neurosurgery at Stanford Medicine. https://t.co/IdtcpUttzd

[CCAD @The_CCAD]

Congratulations to our #CCAD2023 New Vision Investigator Awardee, @christinabyoung! 👏🏻

[Ted Wilson @EdwardWilsonIII]

Wonderful to be included in this @NeurologyToday piece reflecting on the Progress in Early Detection and Treatment of #Alzheimer’s Disease

With comments from Liana Apostolova, Randall Bateman, Gil Rabinovici and myself

#EndAlz

[Tobias Hohl is now @fungalspore.bsky.social @tmhohl71]

1/ I'm fortunate to mentor two awesome PhD students who received @NIH F31 awards. These pay about 26K in salary. In NYC, PhD students earn around 46K, leaving a 20K gap. It turns out that I cannot use R01/R21 funding to pay for this gap and have to rely on discretionary funds.

[Stanford Neurology & Neurological Sciences @Stanford_Neuro]

How far would you go to live better, for longer? Join @chrishemsworth in exploring the boundaries of human potential in #LimitlessWithChrisHemsworth, a Disney+ Original series from @NatGeo Nov 16 on @DisneyPlus featuring our very own @ShaBrainMD. Trailer: https://t.co/hwFL5MUQLu

[Ted Wilson @EdwardWilsonIII]

Very happy to share new work from the @StanfordADRC using the high-throughput & fully-automated Lumipulse platform to measure #Alzheimer blood biomarker🩸 plasma p-tau181 📈
https://t.co/pdfXG1xAZq

@Stanford_Neuro @StanfordBrain #NIAfundedADRC #EndAlz 🧵👇1/4...

[Tony Wyss-Coray @wysscoray]

congratulations to @JarodRutledge1 and @blehall for describing new fluid biomarker AADC for Parkinson's disease in great collaboration with Kathleen Poston @pddoc. https://t.co/Ks9OLjWk4I

[Kathleen L Poston @pddoc]

Pre-print alert! Exciting study from @JarodRutledge1
discovering novel biomarkers in people with #Parkinsons #PD Aromatic L-Amino Acid Decarboxylase is a novel fluid biomarker of Parkinson's disease https://t.co/Eeq2lpw80p

[Kathleen L Poston @pddoc]

Excited to share our new study in #Parkinson #PD ! Aromatic L-Amino Acid Decarboxylase is a novel fluid biomarker of Parkinson's disease https://t.co/Eeq2lpw80p

[Kathleen L Poston @pddoc]

#Stanford_Neuro Dr. Christina Young talking about #Parkinsons dementia at the #SFNS